El-Jamal Mariam, Annan Beyhan, Al Tawil Alaa, Hamati Melissa, Almukdad Sawsan, Fakih Iman, Dabdoub Fatema, Sharara Eman, Jamil Muhammad S, Alaama Ahmed S, Hermez Joumana G, Rowley Jane, Abu-Raddad Laith J, Mumtaz Ghina R
Department of Epidemiology and Population Health, American University of Beirut, Beirut, Lebanon.
Interprofessional Education Office, QU Health, Qatar University, Doha, Qatar.
EClinicalMedicine. 2024 Jul 29;75:102746. doi: 10.1016/j.eclinm.2024.102746. eCollection 2024 Sep.
Syphilis is a sexually transmitted infection (STI) that can be prevented and effectively treated; yet it continues to be a cause of morbidity and mortality worldwide. There is a limited understanding of the epidemiology of syphilis in the Middle East and North Africa (MENA) region.
A systematic review conducted up to April 30, 2024 assessed the prevalence of syphilis and followed PRISMA guidelines, without language and date restrictions. Syphilis infection was categorized based on the diagnostic test type, distinguishing between current and lifetime infections. Pooled mean prevalence estimates were determined through random-effects meta-analyses. Random-effects meta-regression analyses were conducted to investigate sources of heterogeneity between studies and identify factors associated with syphilis prevalence.
The review identified 643 studies based on close to 38 million syphilis tests in the 24 MENA countries. The pooled prevalence for probable current syphilis infection was 0.004% (95% CI: 0.001%-0.025%) among blood donors, 0.48% (95% CI: 0.22%-0.82%) in the general population (pregnant women and other general population groups), 2.76% (95% CI: 1.51%-4.35%) in populations at intermediate risk, 4.18% (95% CI: 2.08%-6.89%) among STI clinic attendees, 12.58% (95% CI: 8.45%-17.35%) among female sex workers, and 22.52% (95% CI: 12.73%-34.06%) among men who have sex with men and transgender people. Meta-regression analyses explained 62% of the prevalence variation and indicated a hierarchical pattern in prevalence by population group, higher prevalence among men, considerable subregional variability, and an annual decline of 3% in prevalence among general population groups and 8% among populations at high risk.
Syphilis prevalence in MENA is comparable to global levels, emphasizing a considerable yet often overlooked disease burden with implications for reproductive health and social well-being. The observed rate of decline in syphilis prevalence and the current response fall short of the global targets. Action is required to control syphilis and mitigate its impact, especially in most affected populations.
Qatar Research, Development, and Innovation Council (ARG01-0524-230273); Qatar National Research Fund (NPRP grant number 9-040-3-008).
梅毒是一种可预防且能有效治疗的性传播感染疾病;然而,它仍是全球发病和死亡的一个原因。对中东和北非(MENA)地区梅毒的流行病学了解有限。
截至2024年4月30日进行的一项系统评价评估了梅毒的患病率,并遵循PRISMA指南,无语言和日期限制。梅毒感染根据诊断测试类型进行分类,区分当前感染和终身感染。通过随机效应荟萃分析确定合并平均患病率估计值。进行随机效应荟萃回归分析以研究研究之间异质性的来源,并确定与梅毒患病率相关的因素。
该评价基于MENA地区24个国家近3800万次梅毒检测确定了643项研究。献血者中可能的当前梅毒感染合并患病率为0.004%(95%置信区间:0.001%-0.025%),普通人群(孕妇和其他普通人群组)中为0.48%(95%置信区间:0.22%-0.82%),中等风险人群中为2.76%(95%置信区间:1.51%-4.35%),性传播感染诊所就诊者中为4.18%(95%置信区间:2.08%-6.89%),女性性工作者中为12.58%(95%置信区间:8.45%-17.35%),男男性行为者和跨性别者中为22.52%(95%置信区间:12.73%-34.06%)。荟萃回归分析解释了62%的患病率差异,并表明按人群组划分的患病率呈分层模式,男性患病率较高,次区域差异较大,普通人群组患病率每年下降3%,高风险人群中患病率每年下降8%。
MENA地区的梅毒患病率与全球水平相当,这凸显了一个相当大但常常被忽视的疾病负担,对生殖健康和社会福祉产生影响。观察到的梅毒患病率下降速度和当前应对措施未达到全球目标。需要采取行动来控制梅毒并减轻其影响,特别是在受影响最严重的人群中。
卡塔尔研究、发展与创新委员会(ARG01-0524-230273);卡塔尔国家研究基金(NPRP资助编号9-040-3-008)。